Artificial Intelligence in Precision Medicine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Artificial Intelligence in Precision Medicine Market

1.1. Definition and Scope

1.1.1. Definition of Artificial Intelligence in Precision Medicine

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Artificial Intelligence in Precision Medicine Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Artificial Intelligence in Precision Medicine Market By Technology

1.2.3. Artificial Intelligence in Precision Medicine Market By Component

1.2.4. Artificial Intelligence in Precision Medicine Market By Therapeutic Application

1.2.5. Artificial Intelligence in Precision Medicine Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Artificial Intelligence in Precision Medicine Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Artificial Intelligence in Precision Medicine Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Artificial Intelligence in Precision Medicine Market By Technology

5.1. Introduction

5.2. Artificial Intelligence in Precision Medicine Revenue By Technology

5.2.1. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast, By Technology, 2020-2032

5.2.2. Machine Learning

5.2.2.1. Machine Learning Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Deep Learning

5.2.3.1. Deep Learning Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Querying Method

5.2.4.1. Querying Method Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Natural Language Processing

5.2.5.1. Natural Language Processing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Context-Aware Processing

5.2.6.1. Context-Aware Processing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Artificial Intelligence in Precision Medicine Market By Component

6.1. Introduction

6.2. Artificial Intelligence in Precision Medicine Revenue By Component

6.2.1. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast, By Component, 2020-2032

6.2.2. Hardware

6.2.2.1. Hardware Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Service

6.2.3.1. Service Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Software

6.2.4.1. Software Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Artificial Intelligence in Precision Medicine Market By Therapeutic Application

7.1. Introduction

7.2. Artificial Intelligence in Precision Medicine Revenue By Therapeutic Application

7.2.1. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast, By Therapeutic Application, 2020-2032

7.2.2. Oncology

7.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Respiratory

7.2.3.1. Respiratory Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Cardiology

7.2.4.1. Cardiology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Neurology

7.2.5.1. Neurology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.6. Others

7.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Artificial Intelligence in Precision Medicine Market By Country 

8.1. North America Artificial Intelligence in Precision Medicine Market Overview

8.2. U.S.

8.2.1. U.S. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

8.2.2. U.S. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

8.2.3. U.S. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

8.3. Canada

8.3.1. Canada Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

8.3.2. Canada Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

8.3.3. Canada Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Artificial Intelligence in Precision Medicine Market By Country

9.1. Europe Artificial Intelligence in Precision Medicine Market Overview

9.2. U.K.

9.2.1. U.K. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.2.2. U.K. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

9.2.3. U.K. Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

9.3. Germany

9.3.1. Germany Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.3.2. Germany Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

9.3.3. Germany Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

9.4. France

9.4.1. France Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.4.2. France Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

9.4.3. France Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

9.5. Spain

9.5.1. Spain Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.5.2. Spain Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

9.5.3. Spain Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.6.2. Rest of Europe Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

9.6.3. Rest of Europe Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Artificial Intelligence in Precision Medicine Market By Country

10.1. Asia Pacific Artificial Intelligence in Precision Medicine Market Overview

10.2. China

10.2.1. China Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.2.2. China Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

10.2.3. China Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

10.3. Japan

10.3.1. Japan Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.3.2. Japan Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

10.3.3. Japan Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

10.4. India

10.4.1. India Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.4.2. India Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

10.4.3. India Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

10.5. Australia

10.5.1. Australia Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.5.2. Australia Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

10.5.3. Australia Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

10.6. South Korea

10.6.1. South Korea Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.6.2. South Korea Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

10.6.3. South Korea Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.7.2. Rest of Asia-Pacific Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

10.7.3. Rest of Asia-Pacific Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Artificial Intelligence in Precision Medicine Market By Country

11.1. Latin America Artificial Intelligence in Precision Medicine Market Overview

11.2. Brazil

11.2.1. Brazil Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.2.2. Brazil Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

11.2.3. Brazil Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

11.3. Mexico

11.3.1. Mexico Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.3.2. Mexico Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

11.3.3. Mexico Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.4.2. Rest of Latin America Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

11.4.3. Rest of Latin America Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Artificial Intelligence in Precision Medicine Market By Country 

12.1. Middle East & Africa Artificial Intelligence in Precision Medicine Market Overview

12.2. GCC

12.2.1. GCC Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.2.2. GCC Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

12.2.3. GCC Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

12.3. South Africa

12.3.1. South Africa Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.3.2. South Africa Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

12.3.3. South Africa Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.4.2. Rest of Middle East & Africa Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Component, 2020-2032

12.4.3. Rest of Middle East & Africa Artificial Intelligence in Precision Medicine Revenue (USD Billion) and Forecast By Therapeutic Application, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Artificial Intelligence in Precision Medicine Market

13.1. Artificial Intelligence in Precision Medicine Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Artificial Intelligence in Precision Medicine Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Novo Nordisk A/S

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2022

14.1.3.2. Novo Nordisk A/S 2022 Artificial Intelligence in Precision Medicine Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. AstraZeneca

14.3. Intel Corporation

14.4. GE Healthcare

14.5. Microsoft Corporation

14.6. NVIDIA Corporation

14.7. Enlitic Inc.

14.8. Alphabet Inc.

14.9. BioXcel Therapeutics Inc.

14.10. Sanofi

14.11. IBM Corporation

14.12. Zephyr AI